Attorney Holland has asked all the Office of General counsel paralegals to individually evaluate the structure and operations of the Board of Regenerative Science agency (BORS). Holland will compile this information to submit to Senator Castor.

Facts:United States Senator Caster is sponsoring a bill that would completely restructure and reorganize the Board of Regenerative Science. She wants the agency to be effective and efficient in administering and enforcing the Human Cloning Act. While she wants the agency to have the proper congressional oversight and executive-level guidance from the President, she also wants the agency to operate free from political pressure.

Senator Caster has requested feedback from the BORS agency.

Questions:

(1) should the agency be formed as an executive or independent agency, and

(a) what are benefits and detriments of forming the BORS as either an executive agency or an independent agency, and

(b) what is an example of at least one Federal executive agency and one Federal independent agency.

(2) should BORS operate as a regulatory agency or a social welfare agency, and

(a) what are the benefits and detriments of operating the agency as a regulatory agency or a social welfare agency, and

(b) what is an example of at least one Federal regulatory agency and one Federal social welfare agency.